Morocco Stockpiles Chloroquine Drug for Potential COVID-19 Treatment
In the eyes of the Moroccan authorities, chloroquine could be a cure for the coronavirus. The Ministry of Health has purchased stocks of nivaquine, an antimalarial drug based on chloroquine, produced by the French group, Sanofi, in its Casablanca factories.
According to RFI, Sanofi Maroc has confirmed this purchase operation, which is accompanied by an additional order. But these stocks of nivaquine will be exported to sub-Saharan Africa where the coronavirus pandemic tends to rage.
On Wednesday, the Head of Government, Saâdeddine El Otmani, wrote on his Twitter account that Plaquenil can be used to treat all COVID-19 patients. Since tests have been carried out in France, there is a rush on Plaquenil stocks in pharmacies, a media outlet reports.
Related Articles
-
Morocco Surpasses Rivals as Spain’s Leading Fruit and Vegetable Importer
7 June 2025
-
Moroccan Beach Town Struggles with Tourism Management Despite Prime Location
7 June 2025
-
Agadir Bypass Highway Project Advances with New Geotechnical Study
7 June 2025
-
Rabat Demolitions Legal, Part of Long-Planned Development: Interior Minister
7 June 2025
-
Morocco Proposes New Law to Combat Used Car Fraud and Protect Buyers
7 June 2025